Zhuhai Rundu Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is SACUBITRIL/VALSARTAN, with a corresponding US DMF Number 35868.
Remarkably, this DMF maintains an Active status since its submission on April 28, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 09, 2021, and payment made on September 20, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II